We have tested this hypothesis and compared the stable utrophin overexpression quantified in the DMD-UTRN-Model with the utrophin that is expressed after treatment of the unedited DMD patient cultures with ezutromid, the lead market candidate in this field until very recently, with positive results. Here, UTRN is linked to Duchenne muscular dystrophy.